Stefan Wiemann

21PUBLICATIONS
139CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer cell biologyAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Jun 06, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model.

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Diana Drago-Garcia, Suvendu Giri, Rishita Chatterjee

|Jan 29, 2025
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer.

Efstathios-Iason Vlachavas, Konstantinos Voutetakis, Vivian Kosmidou

|Feb 06, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer

Pageof 4

Frequent Collaborators

6 joint publications

Rainer Will

5 joint publications

Nishanth Belugali Nataraj

5 joint publications

Yosef Yarden

5 joint publications

Simone Borgoni